Navigation Links
Stemline Therapeutics Raises $12.5 Million
Date:4/9/2008

Proceeds to advance oncology therapeutics targeting cancer stem cells

NEW YORK, April 9, 2008 /PRNewswire/ -- Stemline Therapeutics, Inc., a clinical stage biopharmaceutical company and a leading developer of oncology compounds directed to cancer stem cell targets, today announced that it has completed a $12.5 million round of financing with healthcare funds managed by Pequot Capital Management, Inc.

Stemline's CEO, Ivan Bergstein, MD, said. "We are very pleased to have consummated this transaction with a fund of this caliber. The capital provides us with significant runway to advance our clinical program, while continuing to build out our pipeline, discovery platform, and comprehensive IP estate. Moreover, this financing allows us to continue to strengthen our leadership position in the rapidly emerging cancer stem cell field."

About Stemline Therapeutics, Inc.

Stemline Therapeutics, Inc. is a clinical stage biotechnology company developing novel oncology compounds directed to cancer stem cell targets. Stemline's lead compound, SL-401, targets the interleukin-3 receptor present on multiple hematological cancers including leukemia blasts and leukemia cancer stem cells. SL-401 has demonstrated single agent anti-tumor activity at tolerable doses in a multi-center Phase I human trial. In addition, Stemline is developing a portfolio of compounds directed at this and other high value cancer stem cell targets of a variety of hematological and solid cancers. Stemline has also built a robust discovery platform called "StemScreen(R)" which the Company has utilized to identify multiple compounds that target and impair cancer stem cells. For more information, please visit the Company's website at http://www.stemline.com.


'/>"/>
SOURCE Stemline Therapeutics, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Lorus Therapeutics Announces Exclusive Multinational License Agreement with Zoticon Bioventures for Virulizin(R)
2. Amsterdam Molecular Therapeutics Part of Next Biotech Index
3. Sirion Therapeutics Highlights Pivotal Trial Results of Durezol(TM) at the American Society of Cataract and Refractive Surgery Annual Symposium
4. Alba Therapeutics Announces Appointment of Bruce A. Peacock as its Chief Executive Officer
5. Amsterdam Molecular Therapeutics to Appoint George Morstyn to Supervisory Board
6. DiObex Announces Presentation of Scientific Poster at Annual Meeting of American Society for Clinical Pharmacology and Therapeutics
7. ImaRx Therapeutics Reports Business Update and Financial Results for Fourth Quarter and Full Year 2007
8. Mercury Therapeutics Patents Filed
9. Cell Therapeutics, Inc. Announces Filing of Form 10-K
10. Vicus Therapeutics Announces Participation at 15th International Molecular Medicine Tri-Conference
11. TorreyPines Therapeutics Reports Fourth Quarter and Full Year 2007 Financial Results and Highlights
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/23/2014)... September 23, 2014Researchers from the University of Texas ... new method to improve the reliability and performance ... (CNT), a semiconductor material that has long been ... promising successors to silicon for smaller, faster and ... new paper published in the journal Applied ...
(Date:9/23/2014)... September 23, 2014 Kamal Rashid ... Biomanufacturing Education and Training Center (BETC) and research professor ... BioTalk 2014 , an international two-day event focused ... Sponsored by Global Summits, the event will bring together ... living cells to develop and produce human therapeutics. “The ...
(Date:9/23/2014)... DUBLIN , Sept. 23, 2014 ... of the "Proteomics Markets for Research and ... Other Technologies)" report to their offering. ... trends for proteomics applications, both in their research ... of proteins, including the study of the structure ...
(Date:9/23/2014)... 23, 2014 Follow us ... steady popularity the world over, due to its ... in the marketplace is expected to come from ... developing countries. Several sub-Saharan countries in the African ... already implemented genetically engineered crop production strategies. Rising ...
Breaking Biology Technology:Future flexible electronics based on carbon nanotubes 2Future flexible electronics based on carbon nanotubes 3Future flexible electronics based on carbon nanotubes 4Worcester Polytechnic Institute's Biomanufacturing Expertise to be Featured in Berlin 2Worcester Polytechnic Institute's Biomanufacturing Expertise to be Featured in Berlin 3Proteomics Markets for Research and IVD Applications (Mass Spectrometry, Chromatography, Microarrays, Electrophoresis, Immunoassays, Other Technologies) 2Proteomics Markets for Research and IVD Applications (Mass Spectrometry, Chromatography, Microarrays, Electrophoresis, Immunoassays, Other Technologies) 3Proteomics Markets for Research and IVD Applications (Mass Spectrometry, Chromatography, Microarrays, Electrophoresis, Immunoassays, Other Technologies) 4Rising Focus on Food Security Spurs Growth in the Global Agricultural Biotechnology Market, According to New Report by Global Industry Analysts, Inc. 2Rising Focus on Food Security Spurs Growth in the Global Agricultural Biotechnology Market, According to New Report by Global Industry Analysts, Inc. 3Rising Focus on Food Security Spurs Growth in the Global Agricultural Biotechnology Market, According to New Report by Global Industry Analysts, Inc. 4
... NIOX MINO(R) Set to Dramatically Improve Airway Inflammatory Disease ... Management through Personalized Inflammation Control, NEW PROVIDENCE, N.J., ... that NIOX MINO (http://www.nioxmino.com ), a,hand- held point-of-care ... cleared by the U.S. Food and Drug Administration (FDA).,Physicians ...
... RICHMOND, Va., March 4 Insmed Inc. (Nasdaq,CM: INSM), a developer of ... December 31, 2007., Full-Year 2007 and Recent Company Highlights, ... Completed development of INS-19 (Granulocyte Colony Stimulating ... these products to ...
... First Joint U.S. National Modeling and ... Simulation Meeting on March 11-12, 2008, ... PHST ), a leading provider of software, strategic,consulting, ... its broad-based participation at the inaugural,meeting of the American ...
Cached Biology Technology:FDA Grants Market Clearance to Aerocrine Inc.'s NIOX MINO(R): a New Hand-Held Device to Measure Airway Inflammation in Asthma 2FDA Grants Market Clearance to Aerocrine Inc.'s NIOX MINO(R): a New Hand-Held Device to Measure Airway Inflammation in Asthma 3FDA Grants Market Clearance to Aerocrine Inc.'s NIOX MINO(R): a New Hand-Held Device to Measure Airway Inflammation in Asthma 4Insmed Announces Fourth Quarter and Full-Year 2007 Financial Results 2Insmed Announces Fourth Quarter and Full-Year 2007 Financial Results 3Insmed Announces Fourth Quarter and Full-Year 2007 Financial Results 4Insmed Announces Fourth Quarter and Full-Year 2007 Financial Results 5Insmed Announces Fourth Quarter and Full-Year 2007 Financial Results 6Insmed Announces Fourth Quarter and Full-Year 2007 Financial Results 7Insmed Announces Fourth Quarter and Full-Year 2007 Financial Results 8Insmed Announces Fourth Quarter and Full-Year 2007 Financial Results 9Insmed Announces Fourth Quarter and Full-Year 2007 Financial Results 10Insmed Announces Fourth Quarter and Full-Year 2007 Financial Results 11Pharsight Makes Strong Contribution to Inaugural American Conference on Pharmacometrics 2Pharsight Makes Strong Contribution to Inaugural American Conference on Pharmacometrics 3
(Date:9/23/2014)... or isoforms in microRNAs (miRNAs) before, but assumed that ... in the journal Oncotarget this month, shows ... on geographic subpopulations and gender and that the most ... the one typically listed in the public databases. , ... common than we had previously assumed. The fact that ...
(Date:9/23/2014)... When the body forms new tissues during the ... with each other. For years, scientists believed this ... at Carnegie Mellon University and the University of ... communication is equally if not more crucial. ... the Proceedings of the National Academy of ...
(Date:9/23/2014)... Research by Rice University scientists who are fighting a ... be a clinician,s most powerful ally. , "Recent research ... cyberwarfare against the immune system, and we studied the ... how we might turn the tables on cancer," said ... this week in the Early Edition of the ...
Breaking Biology News(10 mins):Slight alterations in microRNA sequences hold more information than previously thought 2Slight alterations in microRNA sequences hold more information than previously thought 3The mechanics of tissue growth 2Immune system is key ally in cyberwar against cancer 2Immune system is key ally in cyberwar against cancer 3
... single female is nearby, female antbirds will sing over the ... keep their messages from getting through, according to a new ... , a Cell Press publication. Males respond to that interruption ... first evidence that such "signal jamming" and "jamming avoidance" occur ...
... at Birmingham professor Lisa Guay-Woodford, M.D., will receive ... Jean Kaplan International Prize for Advancement in the ... The PKD Foundation and the International Society of ... contributions to the field of polycystic kidney disease ...
... of who will carry the burden but could instead ... economic modeling presented today at "Climate Change: Global Risks, ... Contrary to current cost models for lowering ... of researchers from the University of Cambridge conclude that ...
Cached Biology News:Female birds 'jam' their mates' flirtatious songs 2UAB's Lisa Guay-Woodford earns top international nephrology prize 2UAB's Lisa Guay-Woodford earns top international nephrology prize 3Fighting global warming offers growth and development opportunities 2Fighting global warming offers growth and development opportunities 3
Complement C1q subcomponent subunit C precursor. [Source:Uniprot/SWISSPROT;Acc:P02747] Antigen: Recombinant Protein Epitope Signature Tag (PrEST)....
Monoclonal Mouse Anti-Human Cytokeratin 16 (48 kD)...
Mouse monoclonal [CRC64] to Integrin alpha 2b + beta 3 ( Abpromise for all tested applications). Antigen: Human platelets Entrez Gene ID: 23295 Swiss Protein ID: P05106...
PFM8 Antibody...
Biology Products: